PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042624
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042624
In-Vitro Diagnostics (IVD) Packaging Market size was valued at US$ 9,805.7 Million in 2025, expanding at a CAGR of 5.7% from 2026 to 2033.
In-Vitro Diagnostics (IVD) Packaging refers to specialized packaging solutions used for storing, protecting, transporting, and handling diagnostic products such as test kits, reagents, sample collection containers, and laboratory consumables. These packaging systems are designed to maintain product stability, reduce contamination risks, and support safe usage in hospitals, laboratories, clinics, and home-testing environments. IVD packaging may include plastic containers, glass vials, sterile pouches, labels, caps, and temperature-resistant materials that help preserve sensitive diagnostic substances during transportation and storage. The growing use of rapid testing and molecular diagnostics is encouraging the adoption of secure and user-friendly packaging technologies across healthcare systems worldwide.
The global IVD packaging industry is evolving through the participation of healthcare packaging manufacturers, laboratory solution providers, and medical material companies focusing on safety, traceability, and sustainable production methods. Thermo Fisher Scientific Inc. reported annual revenue above USD 40 billion through its laboratory products, diagnostics, and healthcare technologies business operations. In addition, Gerresheimer AG is continually growing its packaging solutions for pharmaceuticals and diagnostics, which will enhance contamination control, storage efficacy, and the global health care supply chain.
In-Vitro Diagnostics (IVD) Packaging Market- Market Dynamics
Rising adoption of diagnostic testing to support packaging demand
The increasing use of diagnostic testing across hospitals, laboratories, and decentralized healthcare centers is supporting the growth of the In-Vitro Diagnostics (IVD) Packaging Market. Expanding disease screening programs, infectious disease monitoring, and preventive healthcare activities are creating higher demand for safe specimen transport systems, reagent containers, sterile pouches, and protective diagnostic packaging. According to the World Health Organization (WHO) - In Vitro Diagnostics, diagnostic technologies are becoming increasingly important for early disease detection and healthcare accessibility in developing regions. In addition, India's Ministry of Health continues strengthening laboratory infrastructure and diagnostic accessibility through national healthcare initiatives supporting broader testing capabilities.
Companies are therefore expanding healthcare packaging production and regional manufacturing capabilities. Berry Global Inc. announced that its healthcare production capacity could increase by up to 30% across selected facilities through new investments in advanced manufacturing assets. The company has also set up a healthcare manufacturing and R&D facility in Bangalore, India, which will generate over 500 jobs while catering to the needs for healthcare packaging in the region. The above initiatives have helped in improving the reliability, contamination control, and logistics for diagnostic products and laboratory use.
The Global In-Vitro Diagnostics (IVD) Packaging Market is segmented on the basis of Product Type, Product Category, Material Type, Function, End User, and Region.
By material category, plastic-based materials are expected to contribute significantly to the in-vitro diagnostics (IVD) packaging market, as they offer lightweight handling, design flexibility, chemical resistance, and cost-efficient large-scale production capabilities. Diagnostic packaging applications frequently require secure transport of reagents, sample collection containers, test cartridges, and disposable components, where plastic materials help improve portability and reduce breakage risks during storage and transportation. Their compatibility with automated manufacturing and sterile packaging processes also supports expanding healthcare testing activities across laboratories and point-of-care environments. Healthcare packaging manufacturers continue investing in advanced polymer technologies suitable for sensitive diagnostic applications. Amcor plc reported that approximately 90% of its research and development projects are focused on recyclable or reusable packaging solutions designed to support healthcare and specialty packaging requirements. The company has also extended its innovations in high-barrier medical packaging aimed at contamination-sensitive products. These advancements have led to an increased uptake of resilient plastic packaging options for diagnostics and laboratory supplies.
In-Vitro Diagnostics (IVD) Packaging Market- Geographical Insights
The In-Vitro Diagnostics (IVD) Packaging Market is experiencing notable regional expansion as healthcare systems continue strengthening disease detection capabilities, laboratory infrastructure, and decentralized diagnostic services. Among different geographical areas, Asia-Pacific and the Middle East & Africa are anticipated to remain highly influential due to rising healthcare investments, expanding diagnostic accessibility, and growing demand for safe specimen transport and reagent packaging systems. The World Health Organization stated that more than 40,000 in-vitro diagnostic products are currently available worldwide, reflecting the increasing importance of diagnostic technologies in public healthcare systems. In India, the Central Drugs Standard Control Organisation strengthened regulatory frameworks for IVD manufacturing, import, and distribution under MDR-2017, supporting organized growth in diagnostic-related industries. Additionally, India's Production Linked Incentive initiatives for medical devices are encouraging domestic diagnostic manufacturing activities. Companies such as Thermo Fisher Scientific Inc. and Gerresheimer AG continue expanding diagnostic production and healthcare packaging capabilities across Asian markets to support rising laboratory testing activities. These developments are helping improve packaging reliability, product safety, and healthcare supply continuity in emerging diagnostic ecosystems.
Asia-Pacific is expected to maintain strong participation in the IVD packaging industry because of increasing laboratory modernization, biotechnology expansion, and supportive healthcare manufacturing policies across countries such as India, China, Japan, and South Korea. India allows 100% foreign direct investment under the automatic route for medical device manufacturing, including diagnostic technologies, encouraging international production partnerships and infrastructure development.
UAE In-Vitro Diagnostics (IVD) Packaging Market- Country Insights
The UAE is witnessing steady development in the In-Vitro Diagnostics (IVD) Packaging Market due to increasing healthcare modernization, stronger medical device regulations, and expanding laboratory infrastructure across the country. The UAE Ministry of Health and Prevention (MOHAP) continues strengthening regulatory frameworks for medical devices and IVD products through risk-based classification and product registration systems aligned with international standards. In 2025, the UAE took additional steps towards governing their healthcare products by setting up the Emirates Drug Establishment (EDE). It handles various regulatory functions regarding medical devices and diagnostic tools. Such initiatives have been fueling the demand for contamination-resistant vials, specimen bottles, sterile packs, and stable diagnostic packaging. Companies such as Thermo Fisher Scientific Inc. and Gerresheimer AG continue supporting healthcare and laboratory supply activities across Gulf markets through diagnostic technologies and medical packaging infrastructure. The country's increasing focus on healthcare quality, safe transport of diagnostic materials, and advanced laboratory services is helping strengthen the environment for modern IVD packaging applications.
The In-Vitro Diagnostics (IVD) Packaging Market is witnessing steady progress as healthcare testing volumes increase across laboratories, hospitals, and home-based diagnostic settings. The industry includes a mix of global packaging manufacturers, medical material suppliers, and specialized container producers focusing on sterile, secure, and easy-to-handle packaging systems. Companies such as Amcor plc, Gerresheimer AG, Stevanato Group S.p.A., and Corning Incorporated are strengthening diagnostic packaging technologies through improved barrier protection, sustainable materials, and temperature-resistant packaging solutions suitable for sensitive reagents and specimen handling.
The participants in the business sector are equally concentrating on automation, tracking systems, and environmentally friendly methods of production to aid evolving healthcare packaging needs. Strategic collaborations, manufacturing upgrades, and advanced glass and polymer packaging solutions continue to shape industry development. For instance, in October 2025, SGD Pharma introduced energy-efficient manufacturing processes for diagnostic glass vials intended to lower environmental impact while preserving medical-grade quality standards. Such developments are helping companies improve operational efficiency, product reliability, and long-term supply capabilities across the diagnostic packaging ecosystem.
In May 2026, AptarGroup expanded its healthcare dispensing technologies for diagnostic reagent bottles and kits, focusing on precision dosing and improved user safety in laboratory and point-of-care testing environments. The development strengthens diagnostic packaging efficiency by improving reagent handling accuracy, laboratory safety standards, and usability in decentralized testing environments.
In October 2025, SGD Pharma introduced energy-efficient production processes for glass vials used in diagnostic applications, aiming to reduce environmental impact while maintaining pharmaceutical-grade quality standards. The initiative supports sustainable diagnostic packaging manufacturing while ensuring reliable vial performance, product safety, and compliance with healthcare quality requirements.